Geode Capital Management
YTEN

Geode Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-62,497
Closed -$23.7K 4685
2024
Q1
$23.7K Hold
62,497
﹤0.01% 4459
2023
Q4
$15K Hold
62,497
﹤0.01% 4553
2023
Q3
$20.4K Buy
62,497
+27,640
+79% +$9.03K ﹤0.01% 4622
2023
Q2
$77.4K Hold
34,857
﹤0.01% 4407
2023
Q1
$96.2K Sell
34,857
-360
-1% -$994 ﹤0.01% 4348
2022
Q4
$58K Sell
35,217
-92
-0.3% -$152 ﹤0.01% 4554
2022
Q3
$105K Hold
35,309
﹤0.01% 4552
2022
Q2
$79K Hold
35,309
﹤0.01% 4665
2022
Q1
$187K Sell
35,309
-8,072
-19% -$42.8K ﹤0.01% 4414
2021
Q4
$213K Buy
43,381
+3,948
+10% +$19.4K ﹤0.01% 4446
2021
Q3
$239K Buy
39,433
+6,243
+19% +$37.8K ﹤0.01% 4364
2021
Q2
$283K Buy
33,190
+2,530
+8% +$21.6K ﹤0.01% 4193
2021
Q1
$384K Buy
+30,660
New +$384K ﹤0.01% 3896
2020
Q1
Sell
-59,164
Closed -$10K 4192
2019
Q4
$10K Hold
59,164
﹤0.01% 4190
2019
Q3
$29K Hold
59,164
﹤0.01% 4115
2019
Q2
$56K Buy
59,164
+4,240
+8% +$4.01K ﹤0.01% 4069
2019
Q1
$62K Hold
54,924
﹤0.01% 3979
2018
Q4
$45K Hold
54,924
﹤0.01% 4011
2018
Q3
$77K Hold
54,924
﹤0.01% 3976
2018
Q2
$77K Buy
+54,924
New +$77K ﹤0.01% 3925
2017
Q2
Sell
-37,277
Closed -$13K 4117
2017
Q1
$13K Buy
37,277
+702
+2% +$245 ﹤0.01% 4056
2016
Q4
$12K Buy
36,575
+468
+1% +$154 ﹤0.01% 4025
2016
Q3
$16K Buy
36,107
+117
+0.3% +$52 ﹤0.01% 4009
2016
Q2
$29K Hold
35,990
﹤0.01% 3997
2016
Q1
$68 Sell
35,990
-117
-0.3% ﹤0.01% 3916
2015
Q4
$55K Buy
36,107
+3,624
+11% +$5.52K ﹤0.01% 3986
2015
Q3
$44K Buy
32,483
+22
+0.1% +$30 ﹤0.01% 4023
2015
Q2
$121K Sell
32,461
-162,248
-83% -$605K ﹤0.01% 3730
2015
Q1
$120K Buy
194,709
+63,632
+49% +$39.2K ﹤0.01% 3717
2014
Q4
$52K Buy
131,077
+204
+0.2% +$81 ﹤0.01% 3871
2014
Q3
$119K Buy
130,873
+136
+0.1% +$124 ﹤0.01% 3718
2014
Q2
$113K Sell
130,737
-68
-0.1% -$59 ﹤0.01% 3670
2014
Q1
$170K Buy
130,805
+204
+0.2% +$265 ﹤0.01% 3535
2013
Q4
$164K Buy
130,601
+136
+0.1% +$171 ﹤0.01% 3487
2013
Q3
$164K Buy
130,465
+136
+0.1% +$171 ﹤0.01% 3374
2013
Q2
$185K Buy
+130,329
New +$185K ﹤0.01% 3259